About the Authors
- Delphine Meynard
-
* E-mail: meynard-sautet.delphine@mgh.harvard.edu (DM); Lin.Herbert@mgh.harvard.edu (HYL)
Affiliation Program in Anemia Signaling Research, Division of Nephrology, Program in Membrane Biology, Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
- Chia Chi Sun
-
Affiliation Program in Anemia Signaling Research, Division of Nephrology, Program in Membrane Biology, Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
- Qifang Wu
-
Affiliation Program in Anemia Signaling Research, Division of Nephrology, Program in Membrane Biology, Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
- Wenjie Chen
-
Affiliation Program in Anemia Signaling Research, Division of Nephrology, Program in Membrane Biology, Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
- Shanzhuo Chen
-
Affiliation Program in Anemia Signaling Research, Division of Nephrology, Program in Membrane Biology, Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
- Caroline N. Nelson
-
Affiliation Institute for Molecular Bioscience, University of Queensland, St. Lucia, Australia
- Michael J. Waters
-
Affiliation Institute for Molecular Bioscience, University of Queensland, St. Lucia, Australia
- Jodie L. Babitt
-
Affiliation Program in Anemia Signaling Research, Division of Nephrology, Program in Membrane Biology, Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
- Herbert Y. Lin
-
* E-mail: meynard-sautet.delphine@mgh.harvard.edu (DM); Lin.Herbert@mgh.harvard.edu (HYL)
Affiliation Program in Anemia Signaling Research, Division of Nephrology, Program in Membrane Biology, Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
Competing Interests
CCS, JLB and HYL have ownership interest in a start-up company Ferrumax Pharmaceuticals, which has licensed technology from the Massachusetts General Hospital based on their work. DM, QW, WC, SC, CN, MW have none to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: DM JLB HYL. Performed the experiments: DM CCS QW WC SC. Analyzed the data: DM JLB HYL. Wrote the paper: DM JLB HYL. Provided expertise on STAT5 and STAT5b plasmid: CNN MJW. Interpreted the data: DM JLB HYL.